Found 5 results

Name Type of Offering Accepted Date
Conexeu Sciences Inc.
D/A 2025-07-02 14:52:27
Amount To Be Raised $2,531,964
Associated Brokers / Dealers N/A
CIK Number 0002066836
Filed Document 0002060755-25-000024
Exclusions or Exemptions 506b
Accepted Date 2025-07-02 14:52:27
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEVADA
Revenue or Assets Decline to Disclose
Type of Security Equity
Conexeu Sciences Inc.
C/A 2025-07-30 15:36:56
Financial Interest The Intermediary will receive a number of shares of common stock of the issuer that is equal to two percent (2%) of the total number of shares of common stock sold by the issuer in the offering.
Filing Platform Equifund Crowd Funding Portal Inc.
Offering Amount N/A
CIK Number 0002066836
Filed Document 0001062993-25-013287
Accepted Date 2025-07-30 15:36:56
Type of Offering C/A
Security Offered Amount 10000
Security Offered Type Common Stock
State NEVADA
Conexeu Sciences Inc.
C 2025-07-30 11:49:14
Financial Interest The Intermediary will receive a number of shares of common stock of the issuer that is equal to two percent (2%) of the total number of shares of common stock sold by the issuer in the offering.
Filing Platform Equifund Crowd Funding Portal Inc.
Offering Amount N/A
CIK Number 0002066836
Filed Document 0001062993-25-013275
Accepted Date 2025-07-30 11:49:14
Type of Offering C
Security Offered Amount 2500000
Security Offered Type Common Stock
State NEVADA
Conexeu Sciences Inc.
D 2025-05-08 19:24:13
Amount To Be Raised $2,411,964
Associated Brokers / Dealers N/A
CIK Number 0002066836
Filed Document 0001062993-25-008936
Exclusions or Exemptions 506b
Accepted Date 2025-05-08 19:24:13
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEVADA
Revenue or Assets Decline to Disclose
Type of Security Equity
Conexeu Sciences Inc.
D 2025-06-13 14:00:06
Amount To Be Raised $2,200
Associated Brokers / Dealers N/A
CIK Number 0002066836
Filed Document 0002060755-25-000021
Exclusions or Exemptions 506b
Accepted Date 2025-06-13 14:00:06
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEVADA
Revenue or Assets Decline to Disclose
Type of Security Equity